Literature DB >> 15806149

The Ski oncoprotein is upregulated and localized at the centrosomes and mitotic spindle during mitosis.

Katherine Marcelain1, Michael J Hayman.   

Abstract

Ski is an oncoprotein that represses transforming growth factor-beta and nuclear receptor signaling. Despite evidence that relates increased Ski protein levels directly with tumor progression in human cells, the signaling pathways that regulate Ski expression are mostly unidentified. Here we show that the Ski protein levels vary throughout the cell cycle, being lowest at G0/G1. This reduction in Ski protein levels results from proteosomal degradation as suggested by in vivo ubiquitination of Ski and the effects of proteosomal inhibitors. In contrast, an upregulation of the Ski protein was observed in cells going through mitosis. At this stage, we also found that Ski is phosphorylated. In vitro and in vivo data suggest that the phosphorylation of Ski in mitosis is carried out by the main kinase controlling the progression of mitosis, namely cdc2/cyclinB. Interestingly, immunofluorescence experiments, supported by biochemical data, show not only an increase in the Ski protein levels, but also a dramatic redistribution of Ski to the centrosomes and mitotic spindle throughout mitosis. Studies to date on Ski have focused on its role as a transcriptional regulator. However, Ski's increased level and specific relocalization during mitosis suggest that Ski might play a distinct role during this particular phase of the cell cycle.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15806149     DOI: 10.1038/sj.onc.1208631

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  13 in total

1.  Ski protein levels increase during in vitro progression of HPV16-immortalized human keratinocytes and in cervical cancer.

Authors:  Yi Chen; Lucia Pirisi; Kim E Creek
Journal:  Virology       Date:  2013-06-27       Impact factor: 3.616

2.  Chromosomal instability in mouse embryonic fibroblasts null for the transcriptional co-repressor Ski.

Authors:  Katherine Marcelain; Ricardo Armisen; Adam Aguirre; Nobuhide Ueki; Jessica Toro; Clemencia Colmenares; Michael J Hayman
Journal:  J Cell Physiol       Date:  2012-01       Impact factor: 6.384

3.  Identification of Ski as a target for Aurora A kinase.

Authors:  Jocelyn Mosquera; Ricardo Armisen; Hongling Zhao; Diego A Rojas; Edio Maldonado; Julio C Tapia; Alicia Colombo; Michael J Hayman; Katherine Marcelain
Journal:  Biochem Biophys Res Commun       Date:  2011-05-12       Impact factor: 3.575

4.  Novel regulation of Ski protein stability and endosomal sorting by actin cytoskeleton dynamics in hepatocytes.

Authors:  Genaro Vázquez-Victorio; Cassandre Caligaris; Eugenio Del Valle-Espinosa; Marcela Sosa-Garrocho; Nelly R González-Arenas; Guadalupe Reyes-Cruz; Marco A Briones-Orta; Marina Macías-Silva
Journal:  J Biol Chem       Date:  2015-01-05       Impact factor: 5.157

5.  SKI promotes Smad3 linker phosphorylations associated with the tumor-promoting trait of TGFbeta.

Authors:  Qiushi Lin; Dahu Chen; Nikolai A Timchenko; Estela E Medrano
Journal:  Cell Cycle       Date:  2010-05-21       Impact factor: 4.534

6.  The Ski protein negatively regulates Siah2-mediated HDAC3 degradation.

Authors:  Hong-Ling Zhao; Nobuhide Ueki; Michael J Hayman
Journal:  Biochem Biophys Res Commun       Date:  2010-08-04       Impact factor: 3.575

7.  The phosphatidylinositol 3-kinase/Akt pathway regulates transforming growth factor-{beta} signaling by destabilizing ski and inducing Smad7.

Authors:  Arja M Band; Mia Björklund; Marikki Laiho
Journal:  J Biol Chem       Date:  2009-12-18       Impact factor: 5.157

8.  The Ski protein can inhibit ligand induced RARalpha and HDAC3 degradation in the retinoic acid signaling pathway.

Authors:  Hong-Ling Zhao; Nobuhide Ueki; Katherine Marcelain; Michael J Hayman
Journal:  Biochem Biophys Res Commun       Date:  2009-03-31       Impact factor: 3.575

Review 9.  Ski and SnoN, potent negative regulators of TGF-beta signaling.

Authors:  Julien Deheuninck; Kunxin Luo
Journal:  Cell Res       Date:  2009-01       Impact factor: 25.617

10.  Differential regulation of Smad3 and of the type II transforming growth factor-β receptor in mitosis: implications for signaling.

Authors:  Tal Hirschhorn; Lior Barizilay; Nechama I Smorodinsky; Marcelo Ehrlich
Journal:  PLoS One       Date:  2012-08-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.